Unlock instant, AI-driven research and patent intelligence for your innovation.

Processes for preparing phosphorodiamidate morpholino oligomers

A technology of oligomeric compounds and compounds, applied in the field of compounds, can solve the problems of limited pharmacological options for DMD

Active Publication Date: 2019-01-04
SAREPTA THERAPEUTICS INC
View PDF18 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, despite these successes, the pharmacological options available for the treatment of DMD are limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Processes for preparing phosphorodiamidate morpholino oligomers
  • Processes for preparing phosphorodiamidate morpholino oligomers
  • Processes for preparing phosphorodiamidate morpholino oligomers

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0269] Preparation process of Golodirsen

[0270] Provided herein are methods of preparing Golodirsen.

[0271] In one aspect, provided herein are methods of preparing oligomeric compounds of formula (G):

[0272]

[0273] The method described therein comprises the following sequential steps:

[0274] (a) contacting a compound of formula (I) with a deblocking agent:

[0275]

[0276] where R 1 as the carrier medium,

[0277] To form a compound of formula (II):

[0278]

[0279] where R 1 is the carrier medium;

[0280] (b) contacting a compound of formula (II) with compound (B):

[0281]

[0282] to form a compound of formula (III):

[0283]

[0284] where R 1 as the carrier medium;

[0285] (c) exposing a compound of formula (III) to a deblocking agent to form a compound of formula (IV):

[0286]

[0287] where R 1 as the carrier medium;

[0288] (d) contacting a compound of formula (IV) with a compound of formula (DPG):

[0289]

[0290] to...

Embodiment 1

[0544] Example 1: NCP2 anchor synthesis

[0545] Preparation of 1.4-fluoro-3-nitrobenzoic acid methyl ester (1)

[0546]

[0547] 12.7kg of 4-fluoro-3-nitrobenzoic acid was added to a 100L flask, 40kg of methanol and 2.82kg of concentrated sulfuric acid were added. The mixture was stirred at reflux (65°C) for 36 hours. The reaction mixture was cooled to 0 °C. Crystals formed at 38°C. The mixture was kept at 0 °C for 4 hours, then filtered under nitrogen. The 100 L flask was washed with 10 kg of methanol which had been cooled to 0° C., and the filter cake was washed. The solid cake was dried on the funnel for 1 hour, transferred to a tray, and dried in a vacuum oven at room temperature to constant weight 13.695 kg methyl 4-fluoro-3-nitrobenzoate (100% yield; HPLC 99% ).

[0548] 2. Preparation of 3-nitro-4-(2-oxopropyl)benzoic acid

[0549] A. (Z)-4-(3-Hydroxy-1-methoxy-1-oxobut-2-en-2-yl)-3-nitrobenzoic acid methyl ester (2)

[0550]

[0551] To a 100 L flask was...

Embodiment 2

[0570] Example 2: Anchor resin synthesis

[0571] About 52 L of NMP and 2600 g of aminoethyl polystyrene resin were added to a 75 L solid phase synthesis reactor. The resin was stirred in NMP to swell for about 2 hours, then drained. The resin was washed twice with about 39 L of DCM per wash, then twice with 39 L of neutralizing solution per wash, then twice with 39 L of DCM per wash. The NCP2 anchoring solution was slowly added to the stirred resin solution, stirred at room temperature for 24 hr, and drained. The resin was washed four times with 39L NMP per wash and six times with 39L DCM per wash. The resin was treated and stirred with 1 / 2 DEDC capping solution for 30 minutes, drained, and treated with a second 1 / 2 DEDC capping solution and stirred for 30 minutes and drained. The resin was washed six times with 39L DCM each time, and then dried in an oven to a constant weight of 3573.71g to obtain an anchored resin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomer synthesis while maintaining overall yield and purity of a synthesized oligomer.

Description

[0001] related application [0002] This patent application claims U.S. Provisional Patent Application No. 62 / 508,256, filed May 18, 2017, U.S. Provisional Patent Application No. 62 / 341,049, filed May 24, 2016, U.S. Provisional Patent Application No. 62 / 341,049, filed May 24, 2016 Patent Application No. 62 / 340,953, U.S. Provisional Patent Application No. 62 / 357,134, filed June 30, 2016, and U.S. Provisional Patent Application No. 62 / 357,166, filed June 30, 2016, the aforementioned provisional The entire content of the patent application is incorporated herein by reference. Background technique [0003] Antisense technology provides a means to modulate the expression of one or more specific gene products, including alternatively spliced ​​products, and is uniquely useful in many therapeutic, diagnostic and research applications. The principle behind antisense technology is that antisense compounds, such as oligonucleotides, that hybridize to a target nucleic acid modulate gene...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/496A61K31/5377C07D265/30
CPCC07F9/65583C07F9/65616A61K31/675
Inventor B.蔡M.马蒂尼K.托马斯R.施马布库
Owner SAREPTA THERAPEUTICS INC